Cytokine storm in COVID-19—immunopathological mechanisms, clinical considerations, and therapeutic approaches: the REPROGRAM consortium position paper

S Bhaskar, A Sinha, M Banach, S Mittoo… - Frontiers in …, 2020 - frontiersin.org
Cytokine storm is an acute hyperinflammatory response that may be responsible for critical
illness in many conditions including viral infections, cancer, sepsis, and multi-organ failure …

Interplay between interleukin-6 signaling and the vascular endothelium in cytokine storms

S Kang, T Kishimoto - Experimental & molecular medicine, 2021 - nature.com
Abstract Interleukin-6 (IL-6) plays a crucial role in host defense against infection and tissue
injuries and is a bioindicator of multiple distinct types of cytokine storms. In this review, we …

The potential role of cytokine storm pathway in the clinical course of viral respiratory pandemic

G Murdaca, F Paladin, A Tonacci, S Isola, A Allegra… - Biomedicines, 2021 - mdpi.com
The “cytokine storm”(CS) consists of a spectrum of different immune dysregulation disorders
characterized by constitutional symptoms, systemic inflammation and multiorgan dysfunction …

Upregulation of type 1 conventional dendritic cells implicates antigen cross-presentation in multisystem inflammatory syndrome

JJ Huang, SB Gaines, ML Amezcua, TR Lubell… - Journal of Allergy and …, 2022 - Elsevier
Background Multisystem inflammatory syndrome in children (MIS-C) is an acute, febrile,
severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)-associated syndrome …

The proportion of regulatory T cells in the peripheral blood reflects the relapse or remission status of patients with Churg-Strauss syndrome

H Saito, N Tsurikisawa, T Tsuburai… - International archives of …, 2011 - karger.com
Background: Churg-Strauss syndrome (CSS) is a rare, systemic, necrotizing vasculitis that
develops in some asthma patients. We previously reported that maintenance of the …

Involvement of regulatory T cells in the pathogenesis of Churg-Strauss syndrome

H Saito, N Tsurikisawa, T Tsuburai… - International archives of …, 2008 - karger.com
Background: Churg-Strauss syndrome (CSS) is a rare systemic necrotizing vasculitis that
develops in some asthma patients. However, it remains unknown what types of asthma …

Signaling pathways in the regulation of cytokine release syndrome in human diseases and intervention therapy

X Li, M Shao, X Zeng, P Qian, H Huang - Signal Transduction and …, 2021 - nature.com
Cytokine release syndrome (CRS) embodies a mixture of clinical manifestations, including
elevated circulating cytokine levels, acute systemic inflammatory symptoms and secondary …

Mepolizumab as a steroid-sparing treatment option in patients with Churg-Strauss syndrome

S Kim, G Marigowda, E Oren, E Israel… - Journal of Allergy and …, 2010 - Elsevier
BACKGROUND: Treatments for Churg-Strauss syndrome (CSS), a rare eosinophilic
vasculitis characterized by asthma, sinusitis, peripheral eosinophilia, pulmonary infiltrates …

Risk factors of cytokine release syndrome: stress, catecholamines, and beyond

X Xing, X Hu - Trends in Immunology, 2023 - cell.com
Cytokine release syndrome (CRS) is a severe clinical syndrome marked by drastic elevation
of inflammatory cytokines such as interleukin (IL)-1, IL-6, and tumor necrosis factor (TNF) …

Mutations in COPA lead to abnormal trafficking of STING to the Golgi and interferon signaling

A Lepelley, MJ Martin-Niclós, M Le Bihan… - Journal of Experimental …, 2020 - rupress.org
Heterozygous missense mutations in coatomer protein subunit α, COPA, cause a syndrome
overlapping clinically with type I IFN-mediated disease due to gain-of-function in STING, a …